Tim Watts, CFO at Shield Therapeutics #STX presenting at our Life Sciences Investor Briefing Watch Now

Pin to quick picksAvanti Communications Group Plc Broker Ratings (AVN)

  • There is currently no data for AVN

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Broker Recommendations for Avanti Communications Group Plc (AVN)

Date Broker Rating Old Target New Target Change
25-Feb-15JefferiesBuy275.00270.00Reiteration
13-Nov-14Cantor FitzgeraldBuy410.00410.00Reiteration
16-Sep-14Cantor FitzgeraldBuy410.00410.00Reiteration
21-Jul-14JefferiesHold580.00250.00Downgrade
12-Feb-14JefferiesBuy-580.00Reiteration
27-Sep-13JefferiesBuy580.00580.00Reiteration
10-Sep-13JefferiesBuy640.00640.00Reiteration
10-Jul-13JefferiesBuy640.00640.00Reiteration

Login to your account

Don't have an account? Click here to register.